ACAD
ACADIA Pharmaceuticals Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -7.1% ·
aandelenstroom -29.6% ·
netto nieuwe posities -7.7%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 122 | +9 | 90.95M | $2.30B | +11 | −1 |
| Q1 2026 | 115 | -3 | 85.30M | $1.90B | +4 | −8 |
| Q4 2025 | 119 | 0 | 93.96M | $2.51B | +1 | — |
| Q3 2025 | 23 | +1 | 66.53M | $1.42B | +1 | −1 |
| Q2 2025 | 20 | +2 | 61.51M | $1.33B | +2 | — |
| Q1 2025 | 15 | 0 | 22.54M | $374.41M | — | — |
| Q4 2024 | 15 | +1 | 20.32M | $372.93M | +1 | — |
| Q3 2024 | 13 | -1 | 13.63M | $209.57M | — | −1 |
| Q2 2024 | 14 | — | 19.35M | $314.37M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co. ✦ | 3.50M | +19.4% | $53.91M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 3.50M | +19.4% | $53.91M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 2.88M | +1.1% | $44.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 2.88M | +1.1% | $44.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Millennium Management ✦ | 2.05M | -30.1% | $31.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Norges Bank ✦ (passief) | 1.33M | -8.2% | $20.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 1.19M | -57.2% | $18.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 1.11M | +219.3% | $17.08M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 659.96K | -28.3% | $10.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 659.96K | -28.3% | $10.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 403.20K | -15.3% | $6.20M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 194.60K | +19.7% | $2.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 167.56K | -74.4% | $2.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 167.56K | -74.4% | $2.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 62.59K | -3.4% | $962,559 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 62.59K | -3.4% | $962,559 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Wellington Management ✦ | 62.59K | -3.4% | $962,559 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Wellington Management ✦ | 62.59K | -3.4% | $962,559 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 36.93K | +2.0% | $567,953 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 36.93K | +2.0% | $567,953 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 36.93K | +2.0% | $567,953 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 35.73K | +16.8% | $549,466 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Point72 Asset Management | $60.29M | was 0.2% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 337 houders, 164.47M aandelen, $3.62B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.